RNA recognition by HIV-1 Tat and Rev

Seminars in Virology

Volumn 8, Issue 3, 1997, Pages 186-193

  Tan, Ruoying ^a   Brodsky, Alexander ^b   Williamson, James R ^b   Frankel, Alan D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Arginine rich motif; RNA protein interactions; RRE; TAR

Indexed keywords

MESSENGER RNA; REGULATOR PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS RNA;

HUMAN IMMUNODEFICIENCY VIRUS 1; PROTEIN RNA BINDING; REVIEW; RNA PROCESSING; RNA STRUCTURE; RNA TRANSPORT; VIRUS TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 18244423260     PISSN: 10445773     EISSN: None     Source Type: Journal    
DOI: 10.1006/smvy.1997.0121     Document Type: Article

References (82)

1. Kuppuswamy M., Subramanian T., Srinivasan A., Chinnadurai G. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res. 17:1989;3551-3561.
2. Hauber J., Malim M. H., Cullen B. R. Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J. Virol. 63:1989;1181-1187.
3. Ruben S., Perkins A., Purcell R., Joung K., Sia R., Burghoff R., Haseltine W. A., Rosen C. A. Structural and functional characterization of human immunodeficiency virus tat protein. J. Virol. 63:1989;1-8.
4. Derse D., Carvalho M., Carroll R., Peterlin B. M. A minimal lentivirus Tat. J. Virol. 65:1991;7012-7015.
5. Garcia J. A., Harrich D., Soultanakis E., Wu F., Mitsuyasu R., Gaynor R. B. Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J. 8:1989;765-778.
6. Hamy F., Asseline U., Grasby J., Iwai S., Pritchard C., Slim G., Butler P. J., Karn J., Gait M. J. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA. J. Mol. Biol. 230:1993;111-123.
7. Calnan B. J., Tidor B., Biancalana S., Hudson D., Frankel A. D. Arginine-mediated RNA recognition: The arginine fork. Science. 252:1991;1167-1171.
8. Tao J., Frankel A. D. Arginine-binding RNAs resembling TAR identified by in vitro selection. Biochemistry. 35:1996;2229-2238.
9. Weeks K. M., Crothers D. M. RNA recognition by Tat-derived peptides: Interaction in the major groove? Cell. 66:1991;577-588.
10. Riordan F. A., Bhattacharyya A., McAteer S., Lilley D. M. Kinking of RNA helices by bulged bases, and the structure of the human immunodeficiency virus transactivator response element. J. Mol. Biol. 226:1992;305-310.
11. Churcher M. J., Lamont C., Hamy F., Dingwall C., Green S. M., Lowe A. D., Butler J. G., Gait M. J., Karn J. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J. Mol. Biol. 230:1993;90-110.
12. Weeks K. M., Crothers D. M. RNA binding assays for Tat-derived peptides: Implications for specificity. Biochemistry. 31:1992;10281-10287.
13. Tao J., Frankel A. D. Specific binding of arginine to TAR RNA. Proc. Natl. Acad. Sci. USA. 89:1992;2723-2726.
14. Tan R., Frankel A. D. Circular dichroism studies suggest that TAR RNA changes conformation upon specific binding of arginine or guanidine. Biochemistry. 31:1992;10288-10294.
15. Puglisi J. D., Tan R., Calnan B. J., Frankel A. D., Williamson J. R. Conformation of the TAR RNA-arginine complex by NMR spectroscopy. Science. 257:1992;76-80.
16. Aboul-ela F., Karn J., Varani G. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. J. Mol. Biol. 253:1995;313-332.
17. Tao J., Frankel A. D. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins. Proc. Natl. Acad. Sci. USA. 90:1993;1571-1575.
18. Wang Z., Wang X., Rana T. M. Protein orientation in the Tat-TAR complex determined by psoralen photocross-linking. J. Biol. Chem. 271:1996;16995-16998.
19. Zacharias M., Hagerman P. J. The bend in RNA created by the trans-activation response element bulge of human immunodeficiency virus is straightened by arginine and by Tat-derived peptide. Proc. Natl. Acad. Sci. USA. 92:1995;6052-6056.
20. Metzger A. U., Schindler T., Willbold D., Kraft M., Steegborn C., Volkmann A., Frank R. W., Rosch P. Structural rearrangements on HIV-1 Tat (32-72) TAR complex formation. FEBS Lett. 384:1996;255-259.
21. Brodsky A. S., Williamson J. R. Structure of HIV-2 TAR-argininamide complex. J. Mol. Biol. 267:1997;624-639.
22. Aboul-ela F., Karn J., Varani G. Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge. Nucleic Acids Res. 24:1996;3974-3981.
23. Puglisi J. D., Chen L., Frankel A. D., Williamson J. R. Role of RNA structure in arginine recognition of TAR RNA. Proc. Natl. Acad. Sci. USA. 90:1993;3680-3684.
24. Tao J., Chen L., Frankel A. D. Dissection of the proposed base triple in human immunodeficiency virus TAR RNA indicates the importance of the Hoogsteen interaction. Biochemistry. 36:1997;3491-3495.
25. Berkhout B., Silverman R. H., Jeang K. T. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell. 59:1989;273-282.
26. Alonso A., Derse D., Peterlin B. M. Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells. J. Virol. 66:1992;4617-4621.
27. Hart C. E., Saltarelli M. J., Galphin J. C., Schochetman G. A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA. J. Virol. 69:1995;6593-6599.
28. Newstein M., Lee I. S., Venturini D. S., Shank P. R. A chimeric human immunodeficiency virus type 1 TAR region which mediates high level trans-activation in both rodent and human cells. Virology. 197:1993;825-828.
29. Jones K. A., Peterlin B. M. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:1994;717-743.
30. Selby M. J., Peterlin B. M. Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell. 62:1990;769-776.
31. Southgate C., Zapp M. L., Green M. R. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein. Nature. 345:1990;640-642.
32. Southgate C. D., Green M. R. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: Implications for Tat function. Genes Dev. 5:1991;2496-2507.
33. Wu F., Garcia J., Sigman D., Gaynor R. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185. Genes Dev. 5:1991;2128-2140.
34. Sheline C. T., Milocco L. H., Jones K. A. Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. Genes Dev. 5:1991;2508-2520.
35. Wu-Baer F., Lane W. S., Gaynor R. B. The cellular factor TRP-185 regulates RNA polymerase II binding to HIV-1 TAR RNA. EMBO J. 14:1995;5995-6009.
36. Wu-Baer F., Lane W. S., Gaynor R. B. Identification of a group of cellular cofactors that stimulate the binding of RNA polymerase II and TRP-185 to human immunodeficiency virus 1 TAR RNA. J. Biol. Chem. 271:1996;4201-4208.
37. Kao S. Y., Calman A. F., Luciw P. A., Peterlin B. M. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature. 330:1987;489-493.
38. Laspia M. F., Rice A. P., Mathews M. B. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell. 59:1989;283-292.
39. Marciniak R. A., Calnan B. J., Frankel A. D., Sharp P. A. HIV-1 Tat protein trans-activates transcription in vitro. Cell. 63:1990;791-802.
40. Feinberg M. B., Baltimore D., Frankel A. D. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA. 88:1991;4045-4049.
41. Keen N. J., Gait M. J., Karn J. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl. Acad. Sci. USA. 93:1996;2505-2510.
42. Zhou Q., Sharp P. A. Tat-SF1: Cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science. 274:1996;605-610.
43. Herrmann C. H., Rice A. P. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor. J. Virol. 69:1995;1612-1620.
44. Parada C. A., Roeder R. G. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature. 384:1996;375-378.
45. O'Brien T., Hardin S., Greenleaf A., Lis J. T. Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature. 370:1994;75-77.
46. Tiley L. S., Malim M. H., Cullen B. R. Conserved functional organization of the human immunodeficiency virus type 1 and visna virus Rev proteins. J. Virol. 65:1991;3877-3881.
47. Berger J., Aepinus C., Dobrovnik M., Fleckenstein B., Hauber J., Bohnlein E. Mutational analysis of functional domains in the HIV-1 Rev trans-regulatory protein. Virology. 183:1991;630-635.
48. Kjems J., Calnan B. J., Frankel A. D., Sharp P. A. Specific binding of a basic peptide from HIV-1 Rev. EMBO J. 11:1992;1119-1129.
49. Zapp M. L., Hope T. J., Parslow T. G., Green M. R. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proc. Natl. Acad. Sci. USA. 88:1991;7734-7738.
50. Malim M. H., Cullen B. R. HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: Implications for HIV-1 latency. Cell. 65:1991;241-248.
51. Malim M. H., McCarn D. F., Tiley L. S., Cullen B. R. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J. Virol. 65:1991;4248-4254.
52. Hope T. J., Bond B. L., McDonald D., Klein N. P., Parslow T. G. Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif. J. Virol. 65:1991;6001-6007.
53. Malim M. H., Bohnlein S., Hauber J., Cullen B. R. Functional dissection of the HIV-1 Rev trans-activator-derivation of a trans-dominant repressor of Rev function. Cell. 58:1989;205-214.
54. Fischer U., Huber J., Boelens W. C., Mattaj I. W., Luhrmann R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell. 82:1995;475-483.
55. Fritz C. C., Zapp M. L., Green M. R. A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature. 376:1995;530-533.
56. Bogerd H. P., Fridell R. A., Madore S., Cullen B. R. Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell. 82:1995;485-494.
57. Stutz F., Izaurralde E., Mattaj I. W., Rosbash M. A role for nucleoporin FG repeat domains in export of human immunodeficiency virus type 1 Rev protein and RNA from the nucleus. Mol. Cell. Biol. 16:1996;7144-7150.
58. Daly T. J., Rennert P., Lynch P., Barry J. K., Dundas M., Rusche J. R., Doten R. C., Auer M., Farrington G. K. Perturbation of the carboxy terminus of HIV-1 Rev affects multimerization on the Rev responsive element. Biochemistry. 32:1993;8945-8954.
59. Malim M. H., Hauber J., Le S. Y., Maizel J. V., Cullen B. R. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature. 338:1989;254-257.
60. Lee S. W., Gallardo H. F., Gilboa E., Smith C. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain. J. Virol. 68:1994;8254-8264.
61. Mann D. A., Mikaelian I., Zemmel R. W., Green S. M., Lowe A. D., Kimura T., Singh M., Butler P. J., Gait M. J., Karn J. A molecular rheostat: Co-operative rev binding to stem I of the Rev-response element modulates human immunodeficiency virus type-1 late gene expression. J. Mol. Biol. 241:1994;193-207.
62. Tan R., Chen L., Buettner J. A., Hudson D., Frankel A. D. RNA recognition by an isolated alpha helix. Cell. 73:1993;1031-1040.
63. Tan R., Frankel A. D. Costabilization of peptide and RNA structure in an HIV Rev peptide-RRE complex. Biochemistry. 33:1994;14579-14585.
64. Jain C., Belasco J. G. A structural model for the HIV-1 Rev-RRE complex deduced from altered-specificity rev variants isolated by a rapid genetic strategy. Cell. 87:1996;115-125.
65. Bartel D. P., Zapp M. L., Green M. R., Szostak J. W. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell. 67:1991;529-536.
66. Iwai S., Pritchard C., Mann D. A., Karn J., Gait M. J. Recognition of the high affinity binding site in rev-response element RNA by the human immunodeficiency virus type-1 rev protein. Nucleic Acids Res. 20:1992;6465-6472.
67. Symensma T. L., Giver L., Zapp M., Takle G. B., Ellington A. D. RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo. J. Virol. 70:1996;179-187.
68. Xu W., Ellington A. D. Anti-peptide aptamers recognize amino acid sequence and bind a protein epitope. Proc. Natl. Acad. Sci. USA. 93:1996;7475-7480.
69. Battiste J. L., Mao H., Rao N. S., Tan R., Muhandiram D. R., Kay L. E., Frankel A. D., Williamson J. R. Alpha helix major groove recognition in an HIV-1 Rev peptide-RRE RNA complex. Science. 273:1996;1547-1551.
70. Ye X., Gorin A., Ellington A. D., Patel D. J. Deep penetration of an alpha-helix into a widened RNA major groove in the HIV-1 rev peptide-RNA aptamer complex. Nat. Struct. Biol. 3:1996;1026-1033.
71. Huang X., Hope T. J., Bond B. L., McDonald D., Grahl K., Parslow T. G. Minimal Rev-response element for type 1 human immunodeficiency virus. J. Virol. 65:1991;2131-2134.
72. McDonald D., Hope T. J., Parslow T. G. Posttranscriptional regulation by the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex proteins through a heterologous RNA binding site. J. Virol. 66:1992;7232-7238.
73. Venkatesan S., Gerstberger S. M., Park H., Holland S. M., Nam Y. Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA. J. Virol. 66:1992;7469-7480.
74. Shukla R. R., Kimmel P. L., Kumar A. Human immunodeficiency virus type 1 Rev-responsive element RNA binds to host cell-specific proteins. J. Virol. 68:1994;2224-2229.
75. Fischer U., Meyer S., Teufel M., Heckel C., Luhrmann R., Rautmann G. Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO J. 13:1994;4105-4112.
76. Meyer B. E., Malim M. H. The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev. 8:1994;1538-1547.
77. Kjems J., Frankel A. D., Sharp P. A. Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev. Cell. 67:1991;169-178.
78. Kjems J., Sharp P. A. The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assembly. J. Virol. 67:1993;4769-4776.
79. Stutz F., Rosbash M. A functional interaction between Rev and yeast pre-mRNA is related to splicing complex formation. EMBO J. 13:1994;4096-4104.
80. Lu X. B., Heimer J., Rekosh D., Hammarskjold M. L. U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc. Natl. Acad. Sci. USA. 87:1990;7598-7602.
81. Luo Y., Yu H., Peterlin B. M. Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J. Virol. 68:1994;3850-3856.
82. Tange T. O., Jensen T. H., Kjems J. In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32. J. Biol. Chem. 271:1996;10066-10072.